RSS-Feed abonnieren
Bitte kopieren Sie die angezeigte URL und fügen sie dann in Ihren RSS-Reader ein.
https://www.thieme-connect.de/rss/thieme/de/10.1055-s-00059887.xml
CC BY 4.0 · Brazilian Journal of Oncology 2025; 21
DOI: 10.1055/s-0045-1807772
DOI: 10.1055/s-0045-1807772
BREAST TUMORS
1849
POSTER PRESENTATION
Implementation of selective cyclin-dependent kinase 4/6 inhibitors (CDK4/6) in a group of metastatic luminal breast cancer patients in the brazilian public health system
Authors
Publikationsverlauf
Artikel online veröffentlicht:
06. Mai 2025
© 2025. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution 4.0 International License, permitting copying and reproduction so long as the original work is given appropriate credit (https://creativecommons.org/licenses/by/4.0/)
Thieme Revinter Publicações Ltda.
Rua Rego Freitas, 175, loja 1, República, São Paulo, SP, CEP 01220-010, Brazil
Bibliographical Record
Míria Rita Duarte, Fernanda Soraia Gonçalves Silva, Larissa Barboza Antunes, Nayara Ellen Bertoli Costa, Israel Gonçalves Vilaça. Implementation of selective cyclin-dependent kinase 4/6 inhibitors (CDK4/6) in a group of metastatic luminal breast cancer patients in the brazilian public health system. Brazilian Journal of Oncology 2025; 21.
DOI: 10.1055/s-0045-1807772
Míria Rita Duarte, Fernanda Soraia Gonçalves Silva, Larissa Barboza Antunes, Nayara Ellen Bertoli Costa, Israel Gonçalves Vilaça. Implementation of selective cyclin-dependent kinase 4/6 inhibitors (CDK4/6) in a group of metastatic luminal breast cancer patients in the brazilian public health system. Brazilian Journal of Oncology 2025; 21.
DOI: 10.1055/s-0045-1807772